Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes

Claudia Cangemi, Vibe Skov, Michael Kjaer Poulsen, Jonas Amstrup Funder, Waleed O Twal, Mari-Anne Gall, Vibeke E. Hjortdal, Marie Louise Jespersen, Torben A Kruse, Jan Aagard, Hans-Henrik Parving, Steen Knudsen, Poul-Flemming Høilund-Carlsen, Peter Rossing, Jan Erik Henriksen, William Scott Argraves, Lars Melholt Rasmussen

    63 Citations (Scopus)


    Extracellular matrix alterations are important elements in the arterial changes seen in diabetes, being associated with increased vascular stiffness and the development of cardiovascular diseases. However, no biomarkers for diabetes-related arterial changes have been defined.
    Original languageEnglish
    JournalClinical Chemistry (Washington, DC)
    Issue number11
    Pages (from-to)1556-65
    Number of pages10
    Publication statusPublished - 2011


    • Aged
    • Biological Markers
    • Calcium-Binding Proteins
    • Cardiovascular Diseases
    • Carotid Intima-Media Thickness
    • Case-Control Studies
    • Diabetes Mellitus, Type 2
    • Extracellular Matrix
    • Extracellular Matrix Proteins
    • Female
    • Follow-Up Studies
    • Humans
    • Immunoassay
    • Immunohistochemistry
    • Male
    • Mammary Arteries
    • Middle Aged
    • Oligonucleotide Array Sequence Analysis
    • Predictive Value of Tests
    • Prospective Studies
    • Real-Time Polymerase Chain Reaction


    Dive into the research topics of 'Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes'. Together they form a unique fingerprint.

    Cite this